UK Cancer Drugs Fund to reassess 42 agents.
作者信息
Cagney Hannah
出版信息
Lancet Oncol. 2015 Jan;16(1):e8. doi: 10.1016/S1470-2045(14)71137-4. Epub 2014 Nov 21.
Abstract
摘要
相似文献
1
UK Cancer Drugs Fund to reassess 42 agents.英国癌症药物基金将重新评估42种药物。
Lancet Oncol. 2015 Jan;16(1):e8. doi: 10.1016/S1470-2045(14)71137-4. Epub 2014 Nov 21.
2
Cancer Drugs Fund of minimal benefit.疗效甚微的癌症药物基金。
Lancet Oncol. 2017 Jun;18(6):e305. doi: 10.1016/S1470-2045(17)30322-4. Epub 2017 May 5.
3
Careful use of science to advance the debate on the UK Cancer Drugs Fund.谨慎运用科学推动关于英国癌症药物基金的辩论。
JAMA. 2014 Jan 1;311(1):25-6. doi: 10.1001/jama.2013.282839.
4
Most drugs paid for by £1.27bn Cancer Drugs Fund had no "meaningful benefit".由12.7亿英镑癌症药物基金支付费用的大多数药物都没有“显著疗效”。
BMJ. 2017 Apr 28;357:j2097. doi: 10.1136/bmj.j2097.
5
The New and Non-Transparent Cancer Drugs Fund.新型非透明癌症药物基金。
Pharmacoeconomics. 2020 Jan;38(1):1-4. doi: 10.1007/s40273-019-00871-9.
6
Calling time on the Cancer Drugs Fund? Funding the NHS in the age of austerity.叫停癌症药物基金？在财政紧缩时代为国民医疗服务体系提供资金。
Br J Hosp Med (Lond). 2015 Apr;76(4):186-7. doi: 10.12968/hmed.2015.76.4.186.
7
A question of health. The lottery of cancer care.健康问题。癌症治疗的随机性。
Health Serv J. 1997 Dec 18;107(5584):suppl 1-4 following 24.
8
Key changes to cancer care in the UK.英国癌症护理的关键变化。
Br J Nurs. 2015;24(4):S3. doi: 10.12968/bjon.2015.24.Sup4.S3.
9
UK and US governments to fund personalised medicine.英国和美国政府将为个性化医疗提供资金。
Lancet Oncol. 2015 Mar;16(3):e108. doi: 10.1016/S1470-2045(14)71204-5. Epub 2015 Feb 6.
10
British clinic is allowed to deny medicine; decision on cost has broad impact.
N Y Times Web. 2006 Feb 16:A10.
引用本文的文献
1
Can Clinical Guidelines Afford to Ignore Cost Effectiveness? An Ethical Perspective.
Pharmacoeconomics. 2016 Jun;34(6):529-31. doi: 10.1007/s40273-016-0391-2.
Zotero 插件